|
MBI's media team has the skills and relationships with national and international print, online and broadcast media to get your story told.
MBI has a seasoned investor relations team and a proven track record of building or restoring credibility with investors and analysts.
MBI brings a fresh, strategic approach to business development for its clients within the biotechnology, medical device, and life sciences industries.
MBI specializes in branding and rebranding private and public life science companies. A clear and consistent corporate identity is the keystone to a successful communications plan.
MBI understands that corporate credibility is one of the most important assets a company can build and that it is one of the hardest to repair when damaged by a crisis.
MBI's media team has the skills and relationships with national and international print, online and broadcast media to get your story told.
MBI has a seasoned investor relations team and a proven track record of building or restoring credibility with investors and analysts.
MBI brings a fresh, strategic approach to business development for its clients within the biotechnology, medical device, and life sciences industries.
MBI specializes in branding and rebranding private and public life science companies. A clear and consistent corporate identity is the keystone to a successful communications plan.
MBI understands that corporate credibility is one of the most important assets a company can build and that it is one of the hardest to repair when damaged by a crisis.
There are over 1,000 life science industry conferences scheduled around the world each year... Learn More ![]()
06/10/13 - Histogenics Announces Peter Greenleaf as CEO ![]() |
||